PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.\', \'Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.\', \'Department of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0256035
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34398893
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all